RecruitingPhase 2NCT07543120
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Sponsor: Novartis Pharmaceuticals
Ft. Washington, MD · +18 more sites
2 recruiting hypertension studies with a site in Ft. Washington, MD.
Sponsor: Novartis Pharmaceuticals
Ft. Washington, MD · +18 more sites
Sponsor: Novartis Pharmaceuticals
Ft. Washington, MD · Lanham, MD · +27 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.